Bidirectional links between Alzheimer's disease and Niemann-Pick type C disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurobiology of Disease

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2014.05.033PMID 24907492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-β as a biomarker for Alzheimer’s disease: quantification methods in body fluids

  2015cited by this paper
• Associations between serum cholesterol levels and cerebral amyloidosis.

  2014cited by this paper
• Amyloid precursor protein controls cholesterol turnover needed for neuronal activity

  2013influential reference
• Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease

  2013cited by this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cited by this paper
• Amyloid β-protein oligomers and Alzheimer’s disease

  2013cited by this paper
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  2013influential reference
• Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.

  2013cited by this paper
• Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease

  2012influential reference
• Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin.

  2012influential reference
• Amyloid-β metabolism in Niemann-Pick C disease models and patients

  2012influential reference
• Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.

  2012cited by this paper
• The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol

  2012cited by this paper
• Cholesterol-depletion corrects APP and BACE1 misstrafficking in NPC1-deficient cells.

  2012influential reference
• Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update.

  2012cited by this paper
• Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.

  2012cited by this paper
• Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients

  2012cited by this paper
• Apolipoprotein E genotype and neurological disease onset in Niemann–Pick disease, type C1

  2012cited by this paper
• Mammalian NPC1 genes may undergo positive selection and human polymorphisms associate with type 2 diabetes

  2012cited by this paper
• Local cholesterol increase triggers amyloid precursor protein‐Bacel clustering in lipid rafts and rapid endocytosis

  2011cited by this paper
• The pathological process underlying Alzheimer’s disease in individuals under thirty

  2011cited by this paper
• Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment

  2011cited by this paper
• Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer’s

  2011cited by this paper
• Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance.

  2011cited by this paper
• Loss of amyloid precursor protein in a mouse model of Niemann-Pick type C disease exacerbates its phenotype and disrupts tau homeostasis.

  2011influential reference
• Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.

  2011influential reference
• A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

  2011cited by this paper
• P4‐153: Increased Expression of the Lysosomal Cholesterol Transporter NPC1 in Alzheimer's Disease

  2010influential reference
• Common SNPs explain a large proportion of the heritability for human height

  2010cited by this paper
• Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.

  2010influential reference
• Intracellular cholesterol homeostasis and amyloid precursor protein processing.

  2010cited by this paper
• Niemann-Pick type C cells show cholesterol dependent decrease of APP expression at the cell surface and its increased processing through the beta-secretase pathway.

  2010influential reference
• Lipids on Trial: The Search for the Offending Metabolite in Niemann‐Pick type C Disease

  2010cited by this paper
• Epistasis Between Intracellular Cholesterol Trafficking-Related Genes (NPC1 and ABCA1) and Alzheimer's Disease Risk

  2010cited by this paper
• Lipids in Alzheimer's disease: A century-old story.

  2010cited by this paper
• Cholesterol accumulation in Niemann Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts.

  2010cited by this paper
• Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

  2010cited by this paper
• Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann‐Pick type C1‐deficient mouse brains

  2010cited by this paper
• Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry

  2010cited by this paper
• γ-Secretase-dependent amyloid-β is increased in Niemann-Pick type C

  2010influential reference
• Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease

  2010cited by this paper
• Niemann-Pick disease type C

  2010cited by this paper
• Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.

  2009cited by this paper
• Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• Clusterin: a forgotten player in Alzheimer's disease.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase.

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009influential reference
• P2‐242: Simvastatin improves cerebrovascular function and reduces soluble amyloid‐beta, inflammation and oxidative stress in aged APP mice

  2009cited by this paper
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease

  2009influential reference
• NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes

  2008cited by this paper
• Loss of γ-Secretase Function Impairs Endocytosis of Lipoprotein Particles and Membrane Cholesterol Homeostasis

  2008cited by this paper
• Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

  2008cited by this paper
• Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.

  2008cited by this paper
• Cholesterol retention in Alzheimer's brain is responsible for high β-and γ-secretase activities and Aβ production

  2008cited by this paper
• Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population.

  2008cited by this paper
• Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production.

  2008cited by this paper
• Association study of cholesterol-related genes in Alzheimer’s disease

  2007cited by this paper
• Pathway-based approaches for analysis of genomewide association studies.

  2007cited by this paper
• Intracellular amyloid-β in Alzheimer's disease

  2007cited by this paper
• Intracellular amyloid-beta in Alzheimer's disease.

  2007cited by this paper
• Aspects of beta-amyloid as a biomarker for Alzheimer's disease.

  2007cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007cited by this paper
• Microfluorometry of cell membrane dynamics

  2006cited by this paper
• Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

  2005influential reference
• The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease

  2005cited by this paper
• Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein

  2005cited by this paper
• Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial

  2005cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Lipids as Modulators of Proteolytic Activity of BACE

  2005cited by this paper
• Neurodegeneration in Heterozygous Niemann-Pick Type C1 (NPC1) Mouse

  2005cited by this paper
• Feline sphingolipidosis resembling Niemann-Pick disease type C

  2004cited by this paper
• Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease Published, JLR Papers in Press, October 1, 2003. DOI 10.1194/jlr.M300320-JLR200

  2004cited by this paper
• Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.

  2004cited by this paper
• Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease

  2004cited by this paper
• Neurofibrillary tangles in Niemann-Pick disease type C

  2004cited by this paper
• Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease.

  2004cited by this paper
• Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities.

  2004influential reference
• Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.

  2004cited by this paper
• Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

  2004cited by this paper
• Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200

  2004cited by this paper
• Aberrant Phosphorylation of α‐Synuclein in Human Niemann‐Pick Type C1 Disease

  2004cited by this paper
• Rab5-stimulated Up-regulation of the Endocytic Pathway Increases Intracellular β-Cleaved Amyloid Precursor Protein Carboxyl-terminal Fragment Levels and Aβ Production*

  2003cited by this paper
• Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid Production In Vivo

  2003influential reference
• Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

  2003cited by this paper
• Niemann–Pick disease type C

  2003cited by this paper
• Impaired ABCA1-dependent Lipid Efflux and Hypoalphalipoproteinemia in Human Niemann-Pick type C Disease*

  2003cited by this paper
• Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

  2003cited by this paper
• Niemann–Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid β deposition associated with apolipoprotein E ε4 homozygosity

  2002influential reference
• Rescue of neurodegeneration in Niemann-Pick C mice by a prion-promoter-driven Npc1 cDNA transgene.

  2002cited by this paper
• Inhibition of Intracellular Cholesterol Transport Alters Presenilin Localization and Amyloid Precursor Protein Processing in Neuronal Cells

  2002influential reference
• Deregulation of cdk5, Hyperphosphorylation, and Cytoskeletal Pathology in the Niemann–Pick Type C Murine Model

  2002cited by this paper
• Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles.

  2002cited by this paper
• Neurodegeneration in the Niemann-Pick C mouse: glial involvement.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

  2001cited by this paper

• Extracellular vesicles in Niemann pick disease type C: current knowledge and future opportunities

  2026cites this paper
• Heterozygosity in NPC may be associated with neurologic and systemic phenotypes

  2025cites this paper
• New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: a unifying cholesterol hypothesis and new therapeutic approach for AD.

  2025cites this paper
• Miglustat in Alzheimer's Disease Associated With Heterozygous NPC1 Mutation: Exploratory Case Series and Preliminary Findings

  2025cites this paper
• Differential gene expression patterns in Niemann-Pick Type C and Tay-Sachs diseases: Implications for neurodegenerative mechanisms

  2025cites this paper
• Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications

  2025cites this paper
• Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies

  2024cites this paper
• Fatty acid–binding proteins 3, 7, and 8 bind cholesterol and facilitate its egress from lysosomes

  2024cites this paper
• Marine-Derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease.

  2024cites this paper
• Latest advances in mechanisms of epileptic activity in Alzheimer’s disease and dementia with Lewy Bodies

  2024cites this paper
• Plasma phosphorylated-tau217 is increased in Niemann–Pick disease type C

  2024cites this paper
• Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease

  2024cites this paper
• Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?

  2024cites this paper
• Challenges and opportunities in neurometabolic disease treatment with enzyme delivery

  2024cites this paper
• Endogenous Protein-Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex.

  2024cites this paper
• The key roles of organelles and ferroptosis in Alzheimerʼs disease

  2022cites this paper
• Calabria as a Genetic Isolate: A Model for the Study of Neurodegenerative Diseases

  2022cites this paper
• Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms

  2022cites this paper
• Variants in the Niemann-pick type C genes are not associated with Alzheimer's disease: a large case-control study in the Chinese population.

  2022cites this paper
• The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis

  2022cites this paper
• Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation

  2021cites this paper
• Modeling Brain Pathology of Niemann‐Pick Disease Type C Using Patient‐Derived Neurons

  2021cites this paper
• The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C

  2021cites this paper
• Estimated prevalence of Niemann–Pick type C disease in Quebec

  2021cites this paper
• Comprehensive-targeted lipidomic analysis in Niemann-Pick C disease.

  2021cites this paper
• Involvement of the Choroid Plexus in the Pathogenesis of Niemann-Pick Disease Type C

  2021cites this paper
• Homeostasis of Lipid Metabolism in Disorders of the Brain

  2021cites this paper
• Neurodegeneration in Niemann–Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment

  2021influential citation
• Soluble Epoxide Hydrolase Inhibition Ameliorates Phenotype and Cognitive Capabilities in a Murine Model of Niemann Pick Disease Type C

  2021cites this paper
• Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease

  2021cites this paper
• Role of the Endolysosomal Pathway and Exosome Release in Tau Propagation.

  2021cites this paper
• Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1

  2021cites this paper
• Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.

  2020cites this paper
• Sphingolipids in Alzheimer's disease, how can we target them?

  2020cites this paper
• STARD1 and NPC1 expression as pathological markers associated with astrogliosis in post-mortem brains from patients with Alzheimer's disease and Down syndrome

  2020cites this paper
• When lipid homeostasis runs havoc: lipotoxicity links lysosomal dysfunction to autophagy.

  2020cites this paper
• Changes in global gene expression indicate disordered autophagy, apoptosis and inflammatory processes and downregulation of cytoskeletal signalling and neuronal development in patients with Niemann–Pick C disease

  2020cites this paper
• Niemann-Pick Type C Disease: At the Nexus of Neurodegenerative and Neurodevelopmental Disorders

  2020cites this paper
• From beta amyloid to altered proteostasis in Alzheimer's disease.

  2020cites this paper
• From the Entorhinal Region via the Prosubiculum to the Dentate Fascia: Alzheimer Disease-Related Neurofibrillary Changes in the Temporal Allocortex

  2020cites this paper
• Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia

  2019cites this paper
• Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management

  2019cites this paper
• Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.

  2019cites this paper
• The complexity of a monogenic neurodegenerative disease: More than two decades of therapeutic driven research into Niemann-Pick type C disease.

  2019cites this paper
• Endolysosome and Autolysosome Dysfunction in Alzheimer’s Disease: Where Intracellular and Extracellular Meet

  2019cites this paper
• Hematopoietic Npc1 mutation shifts gut microbiota composition in Ldlr−/− mice on a high-fat, high-cholesterol diet

  2019cites this paper
• Do heterozygous mutations of Niemann–Pick type C predispose to late-onset neurodegeneration: a review of the literature

  2019cites this paper
• In vivo evidence of cortical amyloid deposition in the adult form of Niemann Pick type C

  2019cites this paper
• Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia

  2018cites this paper
• Marine derived bioactive compounds for treatment of Alzheimer's disease.

  2018cites this paper
• Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion

  2018cites this paper
• Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC

  2018cites this paper
• Candidate‐based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in A&bgr; and TAU proteostasis

  2018cites this paper
• Endosomal-Lysosomal Cholesterol Sequestration by U18666A Differentially Regulates Amyloid Precursor Protein (APP) Metabolism in Normal and APP-Overexpressing Cells

  2018cites this paper
• Cognition and anatomy of adult Niemann–Pick disease type C: Insights for the Alzheimer field

  2018cites this paper
• N-glycome of the Lysosomal Glycocalyx is Altered in Niemann-Pick Type C Disease (NPC) Model Cells*

  2018cites this paper
• BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains

  2018cites this paper
• Exome sequence analysis of siblings affected with Niemann-Pick type C disease

  2017cites this paper
• Cognitive impairment profile in adult patients with Niemann pick type C disease

  2017cites this paper
• Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype with enhanced lysosomal Ca2+ storage

  2017cites this paper
• Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system

  2017cites this paper
• Investigating ion dyshomeostasis in Niemann-Pick diseasetype C, both in vitro and in vivo

  2017cites this paper
• Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells.

  2017cites this paper
• N-glycome of the lysosomal glycocalyx is altered in Niemann-Pick Type C disease model cells

  2017cites this paper
• Activation of PKC triggers rescue of NPC1 patient specific iPSC derived glial cells from gliosis

  2017cites this paper
• Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice

  2017cites this paper
• Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases

  2017cites this paper
• Aberrant activation of Cdc2/cyclin B1 is involved in initiation of cytoskeletal pathology in murine Niemann-Pick disease type C

  2017cites this paper
• Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model

  2017cites this paper
• The role of epigenetics in lysosomal storage disorders: Uncharted territory.

  2017cites this paper
• Intracellular Cholesterol Trafficking and Impact in Neurodegeneration

  2017influential citation
• Aberrant activation of Cdc2/cyclin B1 is involved in initiation of cytoskeletal pathology in murine Niemann-Pick disease type C

  2017cites this paper
• Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins

  2016cites this paper
• Neuronal gene repression in Niemann-Pick type C models is mediated by the c-Abl/HDAC2 signaling pathway.

  2016cites this paper
• EXPLORING THE ROLE OF MITOCHONDRIAL CHOLESTEROL IN NIEMANN-PICK TYPE C DISEASE

  2016cites this paper
• Anti-amyloidogenic effects of glycosphingolipid synthesis inhibitors occur independently of ganglioside alterations.

  2016cites this paper
• The lysosomal storage disease continuum with ageing-related neurodegenerative disease.

  2016cites this paper
• Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction

  2016cites this paper
• Disease models for the development of therapies for lysosomal storage diseases

  2016cites this paper
• Role of Niemann-Pick Type C Disease Mutations in Dementia

  2016cites this paper
• Genome sequencing in a case of Niemann–Pick type C

  2016cites this paper
• Lysosomal storage disorders and neurodegenerative disease; related mechanisms of pathogenesis and identification of novel therapeutic targets

  2015cites this paper
• Curation of the Mammalian Palmitoylome Indicates a Pivotal Role for Palmitoylation in Diseases and Disorders of the Nervous System and Cancers

  2015cites this paper
• New Drugs from Marine Organisms in Alzheimer’s Disease

  2015cites this paper
• APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.

  2015cites this paper
• Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease.

  2014cites this paper
• Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APPE693Q mice through reduction of ganglioside-bound Aβ

  2014cites this paper